ASO Author Reflections: Is Vascular Cell Adhesion Molecule-1 (VCAM-1) a Promising Biomarker in Urothelial Carcinoma of the Bladder?
Open Access
- 12 April 2022
- journal article
- editorial
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (8) , 5317-5318
Abstract
No abstract availableKeywords
Funding Information
- Medical University of Vienna
This publication has 5 references indexed in Scilit:
- The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical CystectomyEuropean Urology Focus, 2022
- Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical CystectomyAnnals of Surgical Oncology, 2022
- Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysisInternational Journal of Clinical Oncology, 2020
- Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and CancerInternational Journal of Molecular Sciences, 2018
- Nomogram for Predicting Disease Recurrence After Radical Cystectomy for Transitional Cell Carcinoma of the BladderJournal of Urology, 2006